ミルベマイシンオキシムのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Milbemycin Oxime Market Insights, Forecast to 2028

• レポートコード：QY2207E01632 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のミルベマイシンオキシムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にミルベマイシンオキシムの世界市場のxxx％を占める「固体」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「内部害虫駆除」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のミルベマイシンオキシムの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのミルベマイシンオキシム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのミルベマイシンオキシム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ミルベマイシンオキシムのグローバル主要メーカーには、Zhejiang Hisun、Chemwerth、HUBEI HONCH、INOPHA、Hanways Chempharm、Chongqing DaXin Pharmaceutical、Livzon Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ミルベマイシンオキシム市場は、種類と用途によって区分されます。世界のミルベマイシンオキシム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 固体、液体 【用途別セグメント】 内部害虫駆除、外部害虫駆除 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ミルベマイシンオキシム製品概要 - 種類別市場（固体、液体） - 用途別市場（内部害虫駆除、外部害虫駆除） - 調査の目的 ・エグゼクティブサマリー - 世界のミルベマイシンオキシム販売量予測2017-2028 - 世界のミルベマイシンオキシム売上予測2017-2028 - ミルベマイシンオキシムの地域別販売量 - ミルベマイシンオキシムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ミルベマイシンオキシム販売量 - 主要メーカー別ミルベマイシンオキシム売上 - 主要メーカー別ミルベマイシンオキシム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（固体、液体） - ミルベマイシンオキシムの種類別販売量 - ミルベマイシンオキシムの種類別売上 - ミルベマイシンオキシムの種類別価格 ・用途別市場規模（内部害虫駆除、外部害虫駆除） - ミルベマイシンオキシムの用途別販売量 - ミルベマイシンオキシムの用途別売上 - ミルベマイシンオキシムの用途別価格 ・北米市場 - 北米のミルベマイシンオキシム市場規模（種類別、用途別） - 主要国別のミルベマイシンオキシム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのミルベマイシンオキシム市場規模（種類別、用途別） - 主要国別のミルベマイシンオキシム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のミルベマイシンオキシム市場規模（種類別、用途別） - 主要国別のミルベマイシンオキシム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のミルベマイシンオキシム市場規模（種類別、用途別） - 主要国別のミルベマイシンオキシム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのミルベマイシンオキシム市場規模（種類別、用途別） - 主要国別のミルベマイシンオキシム市場規模（トルコ、サウジアラビア） ・企業情報 Zhejiang Hisun、Chemwerth、HUBEI HONCH、INOPHA、Hanways Chempharm、Chongqing DaXin Pharmaceutical、Livzon Group ・産業チェーン及び販売チャネル分析 - ミルベマイシンオキシムの産業チェーン分析 - ミルベマイシンオキシムの原材料 - ミルベマイシンオキシムの生産プロセス - ミルベマイシンオキシムの販売及びマーケティング - ミルベマイシンオキシムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ミルベマイシンオキシムの産業動向 - ミルベマイシンオキシムのマーケットドライバー - ミルベマイシンオキシムの課題 - ミルベマイシンオキシムの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Milbemycin Oxime Market
Due to the COVID-19 pandemic, the global Milbemycin Oxime market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Solid accounting for % of the Milbemycin Oxime global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Internal Pest Control segment is altered to an % CAGR throughout this forecast period.
China Milbemycin Oxime market size is valued at US$ million in 2021, while the US and Europe Milbemycin Oxime are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Milbemycin Oxime landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Milbemycin Oxime include Zhejiang Hisun, Chemwerth, HUBEI HONCH, INOPHA, Hanways Chempharm, Chongqing DaXin Pharmaceutical and Livzon Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Milbemycin Oxime capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Milbemycin Oxime by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Milbemycin Oxime Scope and Segment
Milbemycin Oxime market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Milbemycin Oxime market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Solid
Liquor
Segment by Application
Internal Pest Control
External Pest Control
By Company
Zhejiang Hisun
Chemwerth
HUBEI HONCH
INOPHA
Hanways Chempharm
Chongqing DaXin Pharmaceutical
Livzon Group
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Milbemycin Oxime Product Introduction
1.2 Market by Type
1.2.1 Global Milbemycin Oxime Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Solid
1.2.3 Liquor
1.3 Market by Application
1.3.1 Global Milbemycin Oxime Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Internal Pest Control
1.3.3 External Pest Control
1.4 Study Objectives
1.5 Years Considered
2 Global Milbemycin Oxime Production
2.1 Global Milbemycin Oxime Production Capacity (2017-2028)
2.2 Global Milbemycin Oxime Production by Region: 2017 VS 2021 VS 2028
2.3 Global Milbemycin Oxime Production by Region
2.3.1 Global Milbemycin Oxime Historic Production by Region (2017-2022)
2.3.2 Global Milbemycin Oxime Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Milbemycin Oxime Sales in Volume & Value Estimates and Forecasts
3.1 Global Milbemycin Oxime Sales Estimates and Forecasts 2017-2028
3.2 Global Milbemycin Oxime Revenue Estimates and Forecasts 2017-2028
3.3 Global Milbemycin Oxime Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Milbemycin Oxime Sales by Region
3.4.1 Global Milbemycin Oxime Sales by Region (2017-2022)
3.4.2 Global Sales Milbemycin Oxime by Region (2023-2028)
3.5 Global Milbemycin Oxime Revenue by Region
3.5.1 Global Milbemycin Oxime Revenue by Region (2017-2022)
3.5.2 Global Milbemycin Oxime Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Milbemycin Oxime Production Capacity by Manufacturers
4.2 Global Milbemycin Oxime Sales by Manufacturers
4.2.1 Global Milbemycin Oxime Sales by Manufacturers (2017-2022)
4.2.2 Global Milbemycin Oxime Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Milbemycin Oxime in 2021
4.3 Global Milbemycin Oxime Revenue by Manufacturers
4.3.1 Global Milbemycin Oxime Revenue by Manufacturers (2017-2022)
4.3.2 Global Milbemycin Oxime Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Milbemycin Oxime Revenue in 2021
4.4 Global Milbemycin Oxime Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Milbemycin Oxime Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Milbemycin Oxime Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Milbemycin Oxime Sales by Type
5.1.1 Global Milbemycin Oxime Historical Sales by Type (2017-2022)
5.1.2 Global Milbemycin Oxime Forecasted Sales by Type (2023-2028)
5.1.3 Global Milbemycin Oxime Sales Market Share by Type (2017-2028)
5.2 Global Milbemycin Oxime Revenue by Type
5.2.1 Global Milbemycin Oxime Historical Revenue by Type (2017-2022)
5.2.2 Global Milbemycin Oxime Forecasted Revenue by Type (2023-2028)
5.2.3 Global Milbemycin Oxime Revenue Market Share by Type (2017-2028)
5.3 Global Milbemycin Oxime Price by Type
5.3.1 Global Milbemycin Oxime Price by Type (2017-2022)
5.3.2 Global Milbemycin Oxime Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Milbemycin Oxime Sales by Application
6.1.1 Global Milbemycin Oxime Historical Sales by Application (2017-2022)
6.1.2 Global Milbemycin Oxime Forecasted Sales by Application (2023-2028)
6.1.3 Global Milbemycin Oxime Sales Market Share by Application (2017-2028)
6.2 Global Milbemycin Oxime Revenue by Application
6.2.1 Global Milbemycin Oxime Historical Revenue by Application (2017-2022)
6.2.2 Global Milbemycin Oxime Forecasted Revenue by Application (2023-2028)
6.2.3 Global Milbemycin Oxime Revenue Market Share by Application (2017-2028)
6.3 Global Milbemycin Oxime Price by Application
6.3.1 Global Milbemycin Oxime Price by Application (2017-2022)
6.3.2 Global Milbemycin Oxime Price Forecast by Application (2023-2028)
7 North America
7.1 North America Milbemycin Oxime Market Size by Type
7.1.1 North America Milbemycin Oxime Sales by Type (2017-2028)
7.1.2 North America Milbemycin Oxime Revenue by Type (2017-2028)
7.2 North America Milbemycin Oxime Market Size by Application
7.2.1 North America Milbemycin Oxime Sales by Application (2017-2028)
7.2.2 North America Milbemycin Oxime Revenue by Application (2017-2028)
7.3 North America Milbemycin Oxime Sales by Country
7.3.1 North America Milbemycin Oxime Sales by Country (2017-2028)
7.3.2 North America Milbemycin Oxime Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Milbemycin Oxime Market Size by Type
8.1.1 Europe Milbemycin Oxime Sales by Type (2017-2028)
8.1.2 Europe Milbemycin Oxime Revenue by Type (2017-2028)
8.2 Europe Milbemycin Oxime Market Size by Application
8.2.1 Europe Milbemycin Oxime Sales by Application (2017-2028)
8.2.2 Europe Milbemycin Oxime Revenue by Application (2017-2028)
8.3 Europe Milbemycin Oxime Sales by Country
8.3.1 Europe Milbemycin Oxime Sales by Country (2017-2028)
8.3.2 Europe Milbemycin Oxime Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Milbemycin Oxime Market Size by Type
9.1.1 Asia Pacific Milbemycin Oxime Sales by Type (2017-2028)
9.1.2 Asia Pacific Milbemycin Oxime Revenue by Type (2017-2028)
9.2 Asia Pacific Milbemycin Oxime Market Size by Application
9.2.1 Asia Pacific Milbemycin Oxime Sales by Application (2017-2028)
9.2.2 Asia Pacific Milbemycin Oxime Revenue by Application (2017-2028)
9.3 Asia Pacific Milbemycin Oxime Sales by Region
9.3.1 Asia Pacific Milbemycin Oxime Sales by Region (2017-2028)
9.3.2 Asia Pacific Milbemycin Oxime Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Milbemycin Oxime Market Size by Type
10.1.1 Latin America Milbemycin Oxime Sales by Type (2017-2028)
10.1.2 Latin America Milbemycin Oxime Revenue by Type (2017-2028)
10.2 Latin America Milbemycin Oxime Market Size by Application
10.2.1 Latin America Milbemycin Oxime Sales by Application (2017-2028)
10.2.2 Latin America Milbemycin Oxime Revenue by Application (2017-2028)
10.3 Latin America Milbemycin Oxime Sales by Country
10.3.1 Latin America Milbemycin Oxime Sales by Country (2017-2028)
10.3.2 Latin America Milbemycin Oxime Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Milbemycin Oxime Market Size by Type
11.1.1 Middle East and Africa Milbemycin Oxime Sales by Type (2017-2028)
11.1.2 Middle East and Africa Milbemycin Oxime Revenue by Type (2017-2028)
11.2 Middle East and Africa Milbemycin Oxime Market Size by Application
11.2.1 Middle East and Africa Milbemycin Oxime Sales by Application (2017-2028)
11.2.2 Middle East and Africa Milbemycin Oxime Revenue by Application (2017-2028)
11.3 Middle East and Africa Milbemycin Oxime Sales by Country
11.3.1 Middle East and Africa Milbemycin Oxime Sales by Country (2017-2028)
11.3.2 Middle East and Africa Milbemycin Oxime Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Zhejiang Hisun
12.1.1 Zhejiang Hisun Corporation Information
12.1.2 Zhejiang Hisun Overview
12.1.3 Zhejiang Hisun Milbemycin Oxime Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Zhejiang Hisun Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Zhejiang Hisun Recent Developments
12.2 Chemwerth
12.2.1 Chemwerth Corporation Information
12.2.2 Chemwerth Overview
12.2.3 Chemwerth Milbemycin Oxime Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Chemwerth Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Chemwerth Recent Developments
12.3 HUBEI HONCH
12.3.1 HUBEI HONCH Corporation Information
12.3.2 HUBEI HONCH Overview
12.3.3 HUBEI HONCH Milbemycin Oxime Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 HUBEI HONCH Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 HUBEI HONCH Recent Developments
12.4 INOPHA
12.4.1 INOPHA Corporation Information
12.4.2 INOPHA Overview
12.4.3 INOPHA Milbemycin Oxime Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 INOPHA Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 INOPHA Recent Developments
12.5 Hanways Chempharm
12.5.1 Hanways Chempharm Corporation Information
12.5.2 Hanways Chempharm Overview
12.5.3 Hanways Chempharm Milbemycin Oxime Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Hanways Chempharm Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hanways Chempharm Recent Developments
12.6 Chongqing DaXin Pharmaceutical
12.6.1 Chongqing DaXin Pharmaceutical Corporation Information
12.6.2 Chongqing DaXin Pharmaceutical Overview
12.6.3 Chongqing DaXin Pharmaceutical Milbemycin Oxime Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Chongqing DaXin Pharmaceutical Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Chongqing DaXin Pharmaceutical Recent Developments
12.7 Livzon Group
12.7.1 Livzon Group Corporation Information
12.7.2 Livzon Group Overview
12.7.3 Livzon Group Milbemycin Oxime Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Livzon Group Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Livzon Group Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Milbemycin Oxime Industry Chain Analysis
13.2 Milbemycin Oxime Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Milbemycin Oxime Production Mode & Process
13.4 Milbemycin Oxime Sales and Marketing
13.4.1 Milbemycin Oxime Sales Channels
13.4.2 Milbemycin Oxime Distributors
13.5 Milbemycin Oxime Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Milbemycin Oxime Industry Trends
14.2 Milbemycin Oxime Market Drivers
14.3 Milbemycin Oxime Market Challenges
14.4 Milbemycin Oxime Market Restraints
15 Key Finding in The Global Milbemycin Oxime Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Milbemycin Oxime Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Solid
Table 3. Major Manufacturers of Liquor
Table 4. Global Milbemycin Oxime Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Milbemycin Oxime Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Milbemycin Oxime Production by Region (2017-2022) & (Tons)
Table 7. Global Milbemycin Oxime Production Market Share by Region (2017-2022)
Table 8. Global Milbemycin Oxime Production by Region (2023-2028) & (Tons)
Table 9. Global Milbemycin Oxime Production Market Share by Region (2023-2028)
Table 10. Global Milbemycin Oxime Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Milbemycin Oxime Sales by Region (2017-2022) & (Tons)
Table 12. Global Milbemycin Oxime Sales Market Share by Region (2017-2022)
Table 13. Global Milbemycin Oxime Sales by Region (2023-2028) & (Tons)
Table 14. Global Milbemycin Oxime Sales Market Share by Region (2023-2028)
Table 15. Global Milbemycin Oxime Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Milbemycin Oxime Revenue Market Share by Region (2017-2022)
Table 17. Global Milbemycin Oxime Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Milbemycin Oxime Revenue Market Share by Region (2023-2028)
Table 19. Global Milbemycin Oxime Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Milbemycin Oxime Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Milbemycin Oxime Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Milbemycin Oxime Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Milbemycin Oxime Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Milbemycin Oxime Revenue Share by Manufacturers (2017-2022)
Table 25. Milbemycin Oxime Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Milbemycin Oxime Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Milbemycin Oxime by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Milbemycin Oxime as of 2021)
Table 28. Milbemycin Oxime Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Milbemycin Oxime Product Offered
Table 30. Date of Manufacturers Enter into Milbemycin Oxime Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Milbemycin Oxime Sales by Type (2017-2022) & (Tons)
Table 33. Global Milbemycin Oxime Sales by Type (2023-2028) & (Tons)
Table 34. Global Milbemycin Oxime Sales Share by Type (2017-2022)
Table 35. Global Milbemycin Oxime Sales Share by Type (2023-2028)
Table 36. Global Milbemycin Oxime Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Milbemycin Oxime Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Milbemycin Oxime Revenue Share by Type (2017-2022)
Table 39. Global Milbemycin Oxime Revenue Share by Type (2023-2028)
Table 40. Milbemycin Oxime Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Milbemycin Oxime Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Milbemycin Oxime Sales by Application (2017-2022) & (Tons)
Table 43. Global Milbemycin Oxime Sales by Application (2023-2028) & (Tons)
Table 44. Global Milbemycin Oxime Sales Share by Application (2017-2022)
Table 45. Global Milbemycin Oxime Sales Share by Application (2023-2028)
Table 46. Global Milbemycin Oxime Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Milbemycin Oxime Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Milbemycin Oxime Revenue Share by Application (2017-2022)
Table 49. Global Milbemycin Oxime Revenue Share by Application (2023-2028)
Table 50. Milbemycin Oxime Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Milbemycin Oxime Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Milbemycin Oxime Sales by Type (2017-2022) & (Tons)
Table 53. North America Milbemycin Oxime Sales by Type (2023-2028) & (Tons)
Table 54. North America Milbemycin Oxime Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Milbemycin Oxime Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Milbemycin Oxime Sales by Application (2017-2022) & (Tons)
Table 57. North America Milbemycin Oxime Sales by Application (2023-2028) & (Tons)
Table 58. North America Milbemycin Oxime Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Milbemycin Oxime Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Milbemycin Oxime Sales by Country (2017-2022) & (Tons)
Table 61. North America Milbemycin Oxime Sales by Country (2023-2028) & (Tons)
Table 62. North America Milbemycin Oxime Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Milbemycin Oxime Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Milbemycin Oxime Sales by Type (2017-2022) & (Tons)
Table 65. Europe Milbemycin Oxime Sales by Type (2023-2028) & (Tons)
Table 66. Europe Milbemycin Oxime Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Milbemycin Oxime Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Milbemycin Oxime Sales by Application (2017-2022) & (Tons)
Table 69. Europe Milbemycin Oxime Sales by Application (2023-2028) & (Tons)
Table 70. Europe Milbemycin Oxime Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Milbemycin Oxime Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Milbemycin Oxime Sales by Country (2017-2022) & (Tons)
Table 73. Europe Milbemycin Oxime Sales by Country (2023-2028) & (Tons)
Table 74. Europe Milbemycin Oxime Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Milbemycin Oxime Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Milbemycin Oxime Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Milbemycin Oxime Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Milbemycin Oxime Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Milbemycin Oxime Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Milbemycin Oxime Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Milbemycin Oxime Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Milbemycin Oxime Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Milbemycin Oxime Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Milbemycin Oxime Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Milbemycin Oxime Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Milbemycin Oxime Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Milbemycin Oxime Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Milbemycin Oxime Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Milbemycin Oxime Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Milbemycin Oxime Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Milbemycin Oxime Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Milbemycin Oxime Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Milbemycin Oxime Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Milbemycin Oxime Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Milbemycin Oxime Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Milbemycin Oxime Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Milbemycin Oxime Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Milbemycin Oxime Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Milbemycin Oxime Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Milbemycin Oxime Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Milbemycin Oxime Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Milbemycin Oxime Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Milbemycin Oxime Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Milbemycin Oxime Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Milbemycin Oxime Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Milbemycin Oxime Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Milbemycin Oxime Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Milbemycin Oxime Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Milbemycin Oxime Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Milbemycin Oxime Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Milbemycin Oxime Revenue by Country (2023-2028) & (US$ Million)
Table 112. Zhejiang Hisun Corporation Information
Table 113. Zhejiang Hisun Description and Major Businesses
Table 114. Zhejiang Hisun Milbemycin Oxime Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Zhejiang Hisun Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Zhejiang Hisun Recent Development
Table 117. Chemwerth Corporation Information
Table 118. Chemwerth Description and Major Businesses
Table 119. Chemwerth Milbemycin Oxime Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Chemwerth Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Chemwerth Recent Development
Table 122. HUBEI HONCH Corporation Information
Table 123. HUBEI HONCH Description and Major Businesses
Table 124. HUBEI HONCH Milbemycin Oxime Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. HUBEI HONCH Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. HUBEI HONCH Recent Development
Table 127. INOPHA Corporation Information
Table 128. INOPHA Description and Major Businesses
Table 129. INOPHA Milbemycin Oxime Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. INOPHA Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. INOPHA Recent Development
Table 132. Hanways Chempharm Corporation Information
Table 133. Hanways Chempharm Description and Major Businesses
Table 134. Hanways Chempharm Milbemycin Oxime Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Hanways Chempharm Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hanways Chempharm Recent Development
Table 137. Chongqing DaXin Pharmaceutical Corporation Information
Table 138. Chongqing DaXin Pharmaceutical Description and Major Businesses
Table 139. Chongqing DaXin Pharmaceutical Milbemycin Oxime Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Chongqing DaXin Pharmaceutical Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Chongqing DaXin Pharmaceutical Recent Development
Table 142. Livzon Group Corporation Information
Table 143. Livzon Group Description and Major Businesses
Table 144. Livzon Group Milbemycin Oxime Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Livzon Group Milbemycin Oxime Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Livzon Group Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Milbemycin Oxime Distributors List
Table 150. Milbemycin Oxime Customers List
Table 151. Milbemycin Oxime Market Trends
Table 152. Milbemycin Oxime Market Drivers
Table 153. Milbemycin Oxime Market Challenges
Table 154. Milbemycin Oxime Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Milbemycin Oxime Product Picture
Figure 2. Global Milbemycin Oxime Market Share by Type in 2021 & 2028
Figure 3. Solid Product Picture
Figure 4. Liquor Product Picture
Figure 5. Global Milbemycin Oxime Market Share by Application in 2021 & 2028
Figure 6. Internal Pest Control
Figure 7. External Pest Control
Figure 8. Milbemycin Oxime Report Years Considered
Figure 9. Global Milbemycin Oxime Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 10. Global Milbemycin Oxime Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Milbemycin Oxime Production Market Share by Region (2017-2022)
Figure 12. Global Milbemycin Oxime Production Market Share by Region (2023-2028)
Figure 13. Milbemycin Oxime Production Growth Rate in North America (2017-2028) & (Tons)
Figure 14. Milbemycin Oxime Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 15. Milbemycin Oxime Production Growth Rate in China (2017-2028) & (Tons)
Figure 16. Milbemycin Oxime Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 17. Global Milbemycin Oxime Sales 2017-2028 (Tons)
Figure 18. Global Milbemycin Oxime Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Milbemycin Oxime Revenue 2017-2028 (US$ Million)
Figure 20. Global Milbemycin Oxime Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Milbemycin Oxime Sales Market Share by Region (2017-2022)
Figure 22. Global Milbemycin Oxime Sales Market Share by Region (2023-2028)
Figure 23. North America Milbemycin Oxime Sales YoY (2017-2028) & (Tons)
Figure 24. North America Milbemycin Oxime Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Milbemycin Oxime Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Milbemycin Oxime Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Milbemycin Oxime Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Milbemycin Oxime Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Milbemycin Oxime Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Milbemycin Oxime Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Milbemycin Oxime Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Milbemycin Oxime Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Milbemycin Oxime Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Milbemycin Oxime in the World: Market Share by Milbemycin Oxime Revenue in 2021
Figure 35. Milbemycin Oxime Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Milbemycin Oxime Sales Market Share by Type (2017-2028)
Figure 37. Global Milbemycin Oxime Revenue Market Share by Type (2017-2028)
Figure 38. Global Milbemycin Oxime Sales Market Share by Application (2017-2028)
Figure 39. Global Milbemycin Oxime Revenue Market Share by Application (2017-2028)
Figure 40. North America Milbemycin Oxime Sales Market Share by Type (2017-2028)
Figure 41. North America Milbemycin Oxime Revenue Market Share by Type (2017-2028)
Figure 42. North America Milbemycin Oxime Sales Market Share by Application (2017-2028)
Figure 43. North America Milbemycin Oxime Revenue Market Share by Application (2017-2028)
Figure 44. North America Milbemycin Oxime Sales Share by Country (2017-2028)
Figure 45. North America Milbemycin Oxime Revenue Share by Country (2017-2028)
Figure 46. United States Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Milbemycin Oxime Sales Market Share by Type (2017-2028)
Figure 49. Europe Milbemycin Oxime Revenue Market Share by Type (2017-2028)
Figure 50. Europe Milbemycin Oxime Sales Market Share by Application (2017-2028)
Figure 51. Europe Milbemycin Oxime Revenue Market Share by Application (2017-2028)
Figure 52. Europe Milbemycin Oxime Sales Share by Country (2017-2028)
Figure 53. Europe Milbemycin Oxime Revenue Share by Country (2017-2028)
Figure 54. Germany Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 55. France Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Milbemycin Oxime Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Milbemycin Oxime Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Milbemycin Oxime Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Milbemycin Oxime Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Milbemycin Oxime Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Milbemycin Oxime Revenue Share by Region (2017-2028)
Figure 65. China Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 68. India Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Milbemycin Oxime Sales Market Share by Type (2017-2028)
Figure 75. Latin America Milbemycin Oxime Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Milbemycin Oxime Sales Market Share by Application (2017-2028)
Figure 77. Latin America Milbemycin Oxime Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Milbemycin Oxime Sales Share by Country (2017-2028)
Figure 79. Latin America Milbemycin Oxime Revenue Share by Country (2017-2028)
Figure 80. Mexico Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 83. Colombia Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Milbemycin Oxime Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Milbemycin Oxime Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Milbemycin Oxime Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Milbemycin Oxime Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Milbemycin Oxime Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Milbemycin Oxime Revenue Share by Country (2017-2028)
Figure 90. Turkey Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Milbemycin Oxime Revenue (2017-2028) & (US$ Million)
Figure 93. Milbemycin Oxime Value Chain
Figure 94. Milbemycin Oxime Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

---